Lynk Pharmaceuticals Presents Long-Term Outstanding Service Award to BioDuro-Sundia Chemistry Team
Shanghai, September 25, 2023 – Lynk Pharmaceuticals representatives Dr. Michael Vazquez, Executive Vice President and Head of Chemistry, Dr. Li Xiaodong, Senior Director of Chemistry, and Dr. Su Lin,
September 25, 2023
Congratulate Zhiben Pharma for Receiving China CDE Implied License to Initiate Clinical Trials for Antimicrobial Drug ZB-001
Shanghai, August 1, 2023 – ZB-001, a new antimicrobial drug developed by BioDuro-Sundia partners Zhiben Pharma, has received the implied license from the China CDE to initiate clinical trials. ZB-001
August 01, 2023
BioDuro-Sundia Jiangsu Site Re-establishes Legacy Operations in Radiometric Assays
​Wuxi, July 6, 2023 – Supporting clients in the high-growth in vitro drug discovery industry, BioDuro-Sundia Discovery Biology Department is proud to announce our enhanced formats and selection of biochemica
July 06, 2023
Salubris Pharmaceuticals SAL0119 IND Application for Treatment of Ankylosing Spondylitis and Rheumatoid Arthritis Accepted by FDA
Shanghai, June 30, 2023 – Salubris Pharmaceuticals, a partner of BioDuro-Sundia, announced that an investigational new drug (IND) application for SAL0119 has been accepted by the FDA.
June 30, 2023
BioDuro-Sundia Forms Strategic Partnership with GS Capsule
Shanghai, June 19, 2023 – BioDuro-Sundia and GS Capsule held a Strategic Partnership signing ceremony today in the Shanghai New International Expo Center during CPHI China.
June 19, 2023
Total 78 12345678...1516
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all